ClinicalTrials.gg
CompletedNCT07777393Updated Sep 14, 2026

Fibromyalgia-Related Quality of Life and Exercise Motivation

An observational study in Fibromyalgia, sponsored by University of Beira Interior. Completed at 1 site in Portugal. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-09-14.

Sponsored by University of Beira Interior · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
93
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Fibromyalgia with a site in Portugal — 2 open to participants now, 2 under way, none of them phase 3. Fibromyalgia · Portugal.

Started
2025
the only one that year
Observational
Only one
of the 14
Registered
14th of 14
by date
Lead sponsor
2 of 14
University of Beira Interior

Among the 14 studies in Fibromyalgia with a site in Portugal, this one is the only one that started in 2025, is the only observational one, and was the 14th registered.

Fibromyalgia

1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

Browse Fibromyalgia studies →

Open to participants now

2 of the 14 studies in Fibromyalgia with a site in Portugal are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Fibromyalgia with a site in Portugal, or all of them as a file.
02

Study summary

The objective of this study is to evaluate possible correlations between motivation to engage in physical exercise and quality of life related to fibromyalgia, as well as the level of knowledge about fibromyalgia, and understand the factors that facilitate and the barriers to physical exercise.

Read the detailed description

This is a cross-sectional study in which data will be collected via an online questionnaire from Portuguese citizens with fibromyalgia. Recruitment will take place nationwide, with the project being publicized through organizations and associations related to fibromyalgia. The following questionnaires will be administered: questions regarding knowledge of fibromyalgia, the Fibromyalgia Impact Questionnaire-Revised (FIQ-R), the Tampa Kinesiophobia Scale, the Portuguese version of the Behavioral Regulation in Exercise Questionnaire (BREQ-4), and the Importance of Characteristics Associated with Exercise.

03

Conditions studied

  • Fibromyalgia

Browse trials for

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals with fibromyalgia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • medical diagnosis of fibromyalgia according to the American College of Rheumatology criteria
  • at least 18 years old
  • Portuguese nationality

Exclusion criteria

Exclusion Criteria:

  • medical condition that affects their ability to understand the text
  • illiteracy
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
93 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Portuguese citizens with fibromyalgia

    The form will be completed remotely and consists of 7 sections. These are: Acceptance of the Free, Informed, and Enlightened Consent Form (CLIE); Sociodemographic Information; Assessment of knowledge about the medical condition; The Fibromyalgia Impact Questionnaire Revised (FIQ-R) to assess the degree of impact of fibromyalgia; Tampa Kinesiophobia Scale to assess kinesiophobia; Motivation for physical exercise will be assessed using the Portuguese version of the Behavioral Regulation in Exercise Questionnaire (BREQ-4); and the importance of characteristics associated with exercise will be assessed using an adapted questionnaire.

06

What researchers measure

Primary outcomes

  1. BREQ-4

    Motivation for physical exercise will be assessed using the Portuguese version of the Behavioral Regulation in Exercise Questionnaire (BREQ-4). The questionnaire consists of 21 items, with responses rated on a 5-point Likert scale, where 0: Not true for me; 2: Sometimes true for me; 5: Often true for me. The 21 items are divided into seven factors according to their respective items, which are: amotivation; external regulation ; introjected regulation by avoidance; introjected regulation by approach; identified regulation; integrated regulation and intrinsic motivation. Results will be obtained for each factor/regulation, and the final score that is, the relative autonomy index.

    Time frame: Day 1

Secondary outcomes

  1. Fibromyalgia Impact Questionnaire Revised

    The questionnaire consists of 21 questions, all in an 11-point numerical scale format (0-10). This instrument assesses three domains: 9 items for function, 2 items for overall impact, and 10 items for symptoms. The domain scores are calculated by summing the respective items and dividing by 3 (function domain), 1 (impact domain), and 2 (symptoms domain), and range from 0-30, 0-20, and 0-50, respectively. The total score is calculated by summing the domain scores, resulting in a range of 0 to 100; the higher the score, the greater the impact of fibromyalgia.

    Time frame: Day 1

  2. Fibromyalgia knowledge

    This 20-question questionnaire was developed by researchers and contains statements to be answered as true or false, based on scientific studies; the statements were categorized into: general aspects of fibromyalgia; general treatments; physical exercise; and self-care. The more correct answers a person gives, the greater their knowledge of the condition.

    Time frame: Day 1

  3. Tampa Scale for Kinesiophobia

    Responses are provided using a 4-point Likert scale (1: strongly disagree; 2: disagree; 3: agree; 4: strongly agree). The results are obtained by summing the scores and range from 0 to 52; the higher the score, the greater the perceived fear.

    Time frame: Day 1

  4. Barriers and characteristics associated to exercise

    Twenty questions related to barriers, to which the volunteer must respond with "true" or "false" for each statement regarding the lack of physical activity in their daily life. 14 items to be rated on a 4-point Likert scale based on the degree of importance of characteristics associated with exercise (0: not important; 2: somewhat important; 3: important; 4: very important).

    Time frame: Day 1

07

Study locations

1 site
  • University of Beira Interior
    Covilha, Castelo Branco District 6230-001, Portugal
08

References and documents

Individual participant data

Plan to share: No — In accordance with the Declaration of Helsinki, participant privacy and the confidentiality of personal information will be protected throughout the study. The informed consent obtained from participants does not include authorization for public sharing of individual-level data.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2025 to primary completion in Aug 2026, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2026
First posted
Aug 20, 2026
StartActual
Oct 1, 2025
Primary completionActual
Aug 20, 2026
CompletionActual
Aug 20, 2026
Last update
Sep 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07777393
Lead sponsor
University of Beira Interior
Responsible party
Maria Luiza Laurentino de Albuquerque (Principal Investigator, University of Beira Interior) — Principal investigator
First posted
Aug 20, 2026
Start date
Oct 1, 2025
Primary completion
Aug 20, 2026
Completion
Aug 20, 2026
Last update
Sep 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion